Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Price-to-book ratio

Latest
-68.21
↓ 1016% below average
Average (9y)
-6.11
Historical baseline
Range
High:13.79
Low:-68.21
CAGR
+55.4%
Consistent expansion
PeriodValueChange
2024-68.21-29437.7%
2023-0.23-115.9%
20221.45-89.5%
202113.79+197.2%
2020-14.19-231.9%
201910.76+217.4%
2018-9.16-384.2%
20173.22+18.1%
20162.73+311.8%
2015-1.29-